Trump reschedules MED, with mixed signals on 280E

President Donald Trump's threw a surprise into today's hotly anticipated cannabis reform announcement by rescheduling state licensed MED, while deferring a decision on rescheduling REC to a DEA process later this year.

Since the Nixon administration, marijuana's schedule I status has meant the federal government considers it a dangerous substance with no medical value. Today's announcement moving MED to the much less restrictive schedule III, acknowledges that cannabis has medical value. However, the order, if it holds, could create significantly different financial outcomes for companies, depending on their footprints in MED vs. REC . . .